NIH-funded research R21 grant

Finding new pain-relieving compounds from hemp using AI

Official title: Computation-assisted discovery of bioactive minor cannabinoids from hemp

Funded at Oregon State University · NIH-10791213 · Data updated 2026-11-12

This study is looking at how certain non-psychoactive compounds from hemp might help relieve chronic pain, using advanced technology to find and test these compounds more quickly and effectively.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionOregon State University
NIH-funded
Lab location1 site (Corvallis, United States)
Project startSeptember 25, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$408,375
NIH project number1R21AT012695-01
Project IDNIH-10791213 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from chronic pain who are seeking alternative, non-psychoactive treatment options.

Less likely to help

Patients who do not experience chronic pain or are not interested in cannabinoid-based therapies may not benefit from this research.

What this research studies

This research investigates the therapeutic benefits of minor cannabinoids found in hemp, particularly for chronic pain relief. By integrating Artificial Intelligence into the discovery process, the researchers aim to identify bioactive compounds more efficiently than traditional methods. The study will utilize cell culture models to validate the effects of these cannabinoids, focusing on those that are non-psychoactive. The project leverages industrial-scale hemp extracts to explore previously unstudied cannabinoids for their potential pain-relieving properties.

Why it matters

Potential benefit: If successful, this research could lead to the development of new, effective treatments for chronic pain using natural compounds from hemp.

How similar studies have gone: Other research has shown promise in using cannabinoids for pain relief, but this AI-assisted approach is relatively novel and untested.

Where this research is happening

  • Oregon State University
    Corvallis, United States
    Active

Researchers

  • Principal investigator: Stevens, Jan Frederik — Oregon State University
  • Study coordinator: Stevens, Jan Frederik

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.